Keith Syson Chan
Affiliations: | 2004-2009 | Stem Cell & Regenerative Medicine Center | Stanford University, Palo Alto, CA |
| 2016- | Baylor College of Medicine, Houston, TX | ||
| 2019- | Cedars-Sinai Medical Center, Los Angeles, CA, United States |
Area:
PathologyWebsite:
https://alliedacademies.com/profile/Keith%20Syson%20ChanGoogle:
"Keith Syson Chan"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| John DiGiovanni | grad student | 2004 | The University of Texas Graduate School of Biomedical Sciences at Houston (Chemistry Tree) | |
| (Significance of signal transducer and activator of transcription 3 during multistage mouse skin carcinogenesis.) | ||||
| Irving L. Weissman | post-doc | 2004-2009 | Stanford (FlyTree) | |
Children
Sign in to add trainee| Erica Lay | research assistant | 2010-2012 | Baylor College of Medicine |
| Zoe Tramel | research assistant | 2015-2017 | Baylor College of Medicine |
| Kazukuni Hayashi | grad student | Cedars-Sinai Medical Center | |
| Antonina Kurtova | grad student | 2010-2015 | Baylor College of Medicine |
| Philip Levy Ho | post-doc | Kelsey-Seybold Clinic/Baylor College of Medicine | |
| Fotis Nikolo | post-doc | Cedars-Sinai Medical Center | |
| Yu Cheng Lee | post-doc | 2015-2019 | Baylor College of Medicine |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Heiser CN, Simmons AJ, Revetta F, et al. (2023) Molecular cartography uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors. Cell. 186: 5620-5637.e16 |
| Riveros C, Ranganathan S, Haque W, et al. (2023) Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada |
| Piras R, Ko EY, Barrett C, et al. (2022) circCsnk1g3- and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment. Nature Communications. 13: 7243 |
| You S, Kim M, Hoi XP, et al. (2022) Discoidin domain receptor-driven gene signatures as markers of patient response to anti-PD-L1 immune checkpoint therapy. Journal of the National Cancer Institute |
| Lee YC, Lam HM, Rosser C, et al. (2022) The dynamic roles of the bladder tumour microenvironment. Nature Reviews. Urology |
| You S, Kim M, Widen S, et al. (2022) Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients. Urologic Oncology |
| Nikolos F, Hayashi K, Hoi XP, et al. (2022) Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors. Nature Communications. 13: 1487 |
| Tyner JW, Haderk F, Kumaraswamy A, et al. (2022) Understanding Drug Sensitivity and Tackling Resistance in Cancer. Cancer Research |
| Pollan SG, Teng PC, Jan YJ, et al. (2021) Loss of CDCP1 triggers FAK activation in detached prostate cancer cells. American Journal of Clinical and Experimental Urology. 9: 350-366 |
| Gouin KH, Ing N, Plummer JT, et al. (2021) An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer. Nature Communications. 12: 4906 |